Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease

被引：37

作者：

Hoppe, C ^{[1
]}

Vichinsky, E ^{[1
]}

Quirolo, K ^{[1
]}

Van Warmerdam, J ^{[1
]}

Allen, K ^{[1
]}

Styles, L ^{[1
]}

机构：

[1] Childrens Hosp, Dept Hematol Oncol, Oakland, CA 94609 USA

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2000年 / 22卷 / 04期

关键词：

pediatric; sickle cell anemia; therapy;

D O I：

10.1097/00043426-200007000-00009

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The efficacy and side effects of hydroxyurea in young children with sickle cell disease are unknown. The authors followed-up eight young children (mean age 3.7 years) during therapy with hydroxyurea for an average of 137 weeks. Total and fetal hemoglobin levels rose with hydroxyurea therapy. Hospital admission rates and total hospital days decreased during hydroxyurea therapy. No unexpected toxicity occurred, and growth and development were unaffected. This pilot study suggests that hydroxyurea is safe and effective in young children with sickle cell disease.

引用

页码：330 / 334

页数：5

共 50 条

[31] Hydroxyurea therapy in children severely affected with sickle cell disease
Scott, JP
Hillery, CA
Brown, ER
Misiewicz, V
Labotka, RJ
[J]. JOURNAL OF PEDIATRICS, 1996, 128 (06): : 820 - 828
[32] Pain Experiences in Children with Sickle Cell Disease in the Era of Hydroxyurea
Kavanagh, Patricia
Sprinz, Philippa G.
Libernays, Evelyn
Pavlus, Nicole
Wang, C. Jason
[J]. BLOOD, 2015, 126 (23)
[33] Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease
Wiczling, Pawel
Liem, Robert I.
Panepinto, Julie A.
Garg, Uttam
Abdel-Rahman, Susan M.
Kearns, Gregory L.
Neville, Kathleen A.
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (09): : 1016 - 1022
[34] Alterations in the Humoral Immunophenotype of Children with Sickle Cell Disease on Hydroxyurea
Vistica-Sampino, Emily
Chorzalska, Anna D.
Bonal, Dennis M.
Morgan, John
Nguyen, Lisa
Rodriguez, Anaelena
Lulla, Rishi
Dubielecka, Patrycja M.
[J]. BLOOD, 2022, 140 : 2523 - 2525
[35] Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
Al Sabbah, Mohammed Ali
Radaideh, Mahmoud
Saleh, Shafeeka Mohammed
Al-Doory, Sura Ahmed
Abdalqader, Amal Mahmoud
Mir, Fatima Farid
Mohammed, Aya
[J]. DUBAI MEDICAL JOURNAL, 2023, 6 (04): : 301 - 305
[36] Role of hydroxyurea (HU) in children with sickle cell disease (SCD)
Motwani, J
Lawson, SE
Darbyshire, PJ
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 24 - 25
[37] Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease
Pashankar, Farzana D.
Manwani, Deepa
Lee, Margaret T.
Green, Nancy S.
[J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (03) : 242 - 243
[38] Genetic Predictors of Hydroxyurea Response in Children with Sickle Cell Disease
McDade, Jenny
Flanagan, Jonathan M.
Mortier, Nicole
Smeltzer, Matthew
Howard, Thad A.
Cone, Amy
Hankins, Jane
Aygun, Banu
Wu, Song
Ware, Russell E.
[J]. BLOOD, 2009, 114 (22) : 338 - 338
[39] When Should Hydroxyurea Be Used for Children With Sickle Cell Disease?
Mueller, Brigitta U.
[J]. PEDIATRICS, 2008, 122 (06) : 1365 - 1366
[40] Experts urge wider use of hydroxyurea of sickle cell disease
Traynor, Kate
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (07) : 592 - 593

← 1 2 3 4 5 →